Prospective Observational Study to Determine Kinetics of Procalcitonin in Hospitalized Children Receiving Antibiotic Therapy for Non-Critical Acute Bacterial Infections.
Sophie E KatzJennifer CrookRendie McHenryAndras SzelesNatasha HalasaRitu BanerjeePublished in: Infectious diseases and therapy (2020)
Utility of procalcitonin as a biomarker to follow every 24-48 h in non-critically ill children receiving antibiotic therapy for bacterial infections as an objective measure of clinical improvement is promising.